Skip to content

Reduce Strides Pharma Science; target of Rs 495: ICICI Securities

ICICI Securities recommended reduce rating on Strides Pharma Science with a target price of Rs 495 in its research report dated September 26, 2023.

Read More

​ ICICI Securities recommended reduce rating on Strides Pharma Science with a target price of Rs 495 in its research report dated September 26, 2023. ICICI Securities recommended reduce rating on Strides Pharma Science with a target price of Rs 495 in its research report dated September 26, 2023.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish